vialaudit
The Roundup
aod-9604 · iowa

Is AOD-9604 legal in Iowa?

status · caveats apply
No FDA approval; WADA explicitly names AOD-9604 as a prohibited example under S2.2; PCAC discussed December 4, 2024 (vote pending finalization). No state-level peptide restrictions beyond federal law in Iowa.

category: no approval · last verified May 13, 2026

§ 01

Quick answer

No FDA approval; WADA explicitly names AOD-9604 as a prohibited example under S2.2; PCAC discussed December 4, 2024 (vote pending finalization). No state-level peptide restrictions beyond federal law in Iowa.
§ 02

Full status breakdown

Federal status

FDA approval
no approval
DEA scheduling
not scheduled
503A compounding
Bulks list: voted no
Do-not-compound list: not on list
December 4, 2024 PCAC voted against inclusion. Final 503A list amendment pending.
PCAC review history
FDA Warning Letters
  • Jan 26, 2022 — Innoveix Pharmaceuticals Inc. (cited: aod-9604, sermorelin, ipamorelin) · letter ↗
Shortage status
not currently on shortage list
Sale framing
Research-use-only posture: Standard FDA posture — RUO does not protect sellers when human-use intent is evident.
Personal possession: Not federally scheduled; possession not federally criminalized.

Iowa — state-specific

Sport-body status

WADA 2026
on prohibited list · class S2.2 · both
Explicitly named: WADA's growth-hormone narrative specifically lists AOD-9604 and hGH 176-191 as prohibited examples.
USADA
NCAA

What we couldn’t verify

§ 03

Also known as

AOD-9604 is also marketed or referenced under the following names (vendor pseudonyms, brand names, chemical identifiers):

  • hGH fragment 176-191
  • Advanced Obesity Drug 9604
  • Tyr-hGH(177-191)
  • AOD9604 acetate
§ 04

Disclaimer

§ 05

Related

the roundup · monthly

Receipts in your inbox. Once a month.

New audits, expired coupons pruned, lab notes from vials still on the bench. No marketing. No lifestyle copy. Unsubscribe in one click.

14,200 subscribers· 0 sponsored items· 11 issues since launch